Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · IEX Real-Time Price · USD
3.700
-0.270 (-6.80%)
At close: Apr 19, 2024, 4:00 PM
3.770
+0.070 (1.89%)
After-hours: Apr 19, 2024, 5:20 PM EDT
Harvard Bioscience Market Cap
Harvard Bioscience has a market cap or net worth of $160.58 million as of April 19, 2024. Its market cap has decreased by -20.86% in one year.
Market Cap
160.58M
Enterprise Value
199.07M
1-Year Change
-20.86%
Ranking
Category
Stock Price
$3.70
Market Cap Chart
Since March 19, 2001, Harvard Bioscience's market cap has decreased from $173.50M to $160.58M, a decrease of -7.45%. That is a compound annual growth rate of -0.33%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 18, 2024 | 172.30M | -2.93% |
Apr 17, 2024 | 177.50M | -2.15% |
Apr 16, 2024 | 181.40M | -5.86% |
Apr 15, 2024 | 192.70M | 4.73% |
Apr 12, 2024 | 184.00M | -2.44% |
Apr 11, 2024 | 188.60M | 2.00% |
Apr 10, 2024 | 184.90M | -7.96% |
Apr 9, 2024 | 200.90M | 7.38% |
Apr 8, 2024 | 187.10M | -4.64% |
Apr 5, 2024 | 196.20M | 1.13% |
Apr 4, 2024 | 194.00M | 6.42% |
Apr 3, 2024 | 182.30M | 0.72% |
Apr 2, 2024 | 181.00M | -2.11% |
Apr 1, 2024 | 184.90M | 0.49% |
Mar 28, 2024 | 184.00M | 0.93% |
Mar 27, 2024 | 182.30M | 4.47% |
Mar 26, 2024 | 174.50M | -2.62% |
Mar 25, 2024 | 179.20M | -0.99% |
Mar 22, 2024 | 181.00M | -4.33% |
Mar 21, 2024 | 189.20M | -0.94% |
Mar 20, 2024 | 191.00M | - |
Mar 19, 2024 | 191.00M | 6.05% |
Mar 18, 2024 | 180.10M | 2.45% |
Mar 15, 2024 | 175.80M | -5.59% |
Mar 14, 2024 | 186.20M | -2.26% |
View and export this data all the way back to 2001.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
908 Devices | 183.97M |
Semler Scientific | 180.42M |
Genfit | 180.36M |
Trevi Therapeutics | 177.92M |
The Joint | 177.61M |
Cellectis | 176.51M |
YS Biopharma Co. | 176.28M |
Capricor Therapeutics | 174.84M |